¥6.10   ( %)
前日收盘:6.10 当日成交量(股):9.70万 当日最高:6.10 总股本:5714.25万
当日开盘:6.05 当日成交额(元):58.71万 当日最低:6.00 流通股本:
市盈率(动/静):-8.71/-12.45 市净率:5.26 市销率:171.76 总市值:3.49亿
52周最高:9.96 52周最低:5.05 转让方式: 单位:美元
$Corbus(CRBP)$
  • 还可以输入
  • 20016

Corbus(CRBP) 06月14日 02时14分

查看全文

Corbus(CRBP) 06月10日 14时34分

新闻 Corbus Pharmaceuticals Appoints Former Director of FDA Office of New Drugs John K. Jenkins, MD to Board of Directors - Distinguished 25-year career serving at the U.S. ......  url.vc.watch/giJv
查看全文

Corbus(CRBP) 06月07日 02时17分

公告 Corbus Pharmaceuticals Holdings, Inc. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Jenkins John Kenneth
公告日:2018-06-06, 内部交易人:Jenkins John Kenneth, 与发行人关系:董事/, 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-06-05, SEC Accession No. 0001209191-18-035975, File:https://www.sec.gov/Archives/edgar/data/1595097/000120919118035975/0001209191-18-035975-index.htm $Corbus(CRBP)$
查看全文

Corbus(CRBP) 06月07日 02时17分

查看全文

Corbus(CRBP) 06月07日 02时17分

查看全文

Corbus(CRBP) 05月30日 04时20分

公告 Corbus Pharmaceuticals Holdings, Inc. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Panayiotopoulos Paris
公告日:2018-05-29, 内部交易人:Panayiotopoulos Paris, 与发行人关系:董事/, 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-05-24, SEC Accession No. 0001209191-18-033781, File:https://www.sec.gov/Archives/edgar/data/1595097/000120919118033781/0001209191-18-033781-index.htm $Corbus(CRBP)$
查看全文

Corbus(CRBP) 05月30日 04时20分

公告 Corbus Pharmaceuticals Holdings, Inc. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:HOLMER ALAN F
公告日:2018-05-29, 内部交易人:HOLMER ALAN F, 与发行人关系:董事/, 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-05-24, SEC Accession No. 0001209191-18-033772, File:https://www.sec.gov/Archives/edgar/data/1595097/000120919118033772/0001209191-18-033772-index.htm $Corbus(CRBP)$
查看全文

Corbus(CRBP) 05月30日 04时20分

公告 Corbus Pharmaceuticals Holdings, Inc. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Hochman David P
公告日:2018-05-29, 内部交易人:Hochman David P, 与发行人关系:董事/, 操作:赠与(G),220000(股)Common Stock; 操作:赠与(G),110000(股)Common Stock; 操作:赠与(G),110000(股)Common Stock; 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-05-24, SEC Accession No. 0001209191-18-033770, File:https://www.sec.gov/Archives/edgar/data/1595097/000120919118033770/0001209191-18-033770-index.htm $Corbus(CRBP)$
查看全文

Corbus(CRBP) 05月30日 04时20分

公告 Corbus Pharmaceuticals Holdings, Inc. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:CATLIN AVERY W
公告日:2018-05-29, 内部交易人:CATLIN AVERY W, 与发行人关系:董事/, 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-05-24, SEC Accession No. 0001209191-18-033766, File:https://www.sec.gov/Archives/edgar/data/1595097/000120919118033766/0001209191-18-033766-index.htm $Corbus(CRBP)$
查看全文

Corbus(CRBP) 05月25日 04时45分

查看全文

Corbus(CRBP) 05月24日 23时58分

新闻 Corbus Pharmaceuticals Adds Two Key Executives to Lead its Regulatory and CMC Operations
— Robert Discordia, Ph.D., named Vice President, Pharmaceutical Development &am ......  url.vc.watch/fQx4
查看全文

Corbus(CRBP) 05月24日 23时58分

新闻 Corbus Pharmaceuticals to Present at the Jefferies 2018 Global Healthcare Conference
- Live audio presentation and webcast on Wednesday, June 6th at 9:00 a.m. EDT - ......  url.vc.watch/fQxb
查看全文

Corbus(CRBP) 05月20日 22时56分

新闻 Corbus Pharmaceuticals Announces Acceptance of Three Abstracts for Presentation at EULAR 2018 Annual Meeting - Data from Phase 2 one-year open-label extension of lenaba ......  url.vc.watch/fRt5
查看全文

Corbus(CRBP) 05月20日 22时56分

新闻 Research Report Identifies Bio-Rad Laboratories, Bright Horizons Family Solutions, Corbus Pharmaceuticals, PennyMac Financial Services, TeleTech, and Matrix Service with ......  url.vc.watch/fRtY
查看全文

Corbus(CRBP) 05月17日 02时14分

公告 Corbus Pharmaceuticals Holdings, Inc. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:White Barbara
公告日:2018-05-16, 内部交易人:White Barbara, 与发行人关系:Chief Medical Officer/高管/, 操作:买入,2586(股)Common Stock,均价$5.8679; 报告日:2018-05-15, SEC Accession No. 0001209191-18-030426, File:https://www.sec.gov/Archives/edgar/data/1595097/000120919118030426/0001209191-18-030426-index.htm $Corbus(CRBP)$
查看全文

Corbus(CRBP) 05月17日 02时14分

公告 Corbus Pharmaceuticals Holdings, Inc. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Cohen Yuval
公告日:2018-05-16, 内部交易人:Cohen Yuval, 与发行人关系:Chief Executive Officer/董事/高管/, 操作:买入,1725(股)Common Stock,均价$5.8500; 报告日:2018-05-15, SEC Accession No. 0001209191-18-030366, File:https://www.sec.gov/Archives/edgar/data/1595097/000120919118030366/0001209191-18-030366-index.htm $Corbus(CRBP)$
查看全文

Corbus(CRBP) 05月16日 02时29分

公告 Corbus Pharmaceuticals Holdings, Inc. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Hochman David P
公告日:2018-05-15, 内部交易人:Hochman David P, 与发行人关系:董事/, 操作:买入,5000(股)Common Stock,均价$5.4750; 报告日:2018-05-14, SEC Accession No. 0001209191-18-030144, File:https://www.sec.gov/Archives/edgar/data/1595097/000120919118030144/0001209191-18-030144-index.htm $Corbus(CRBP)$
查看全文

Corbus(CRBP) 05月16日 02时29分

公告 Corbus Pharmaceuticals Holdings, Inc. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Moran Sean F.
公告日:2018-05-15, 内部交易人:Moran Sean F., 与发行人关系:Chief Financial Officer/高管/, 操作:买入,4000(股)Common Stock,均价$5.7700; 报告日:2018-05-15, SEC Accession No. 0001209191-18-030106, File:https://www.sec.gov/Archives/edgar/data/1595097/000120919118030106/0001209191-18-030106-index.htm $Corbus(CRBP)$
查看全文

Corbus(CRBP) 05月12日 18时34分

新闻 Corbus Pharmaceuticals Reports 2018 First Quarter Financial Results and Provides Business Update
- Company continues to make consistent progress in the clinical develop ......  url.vc.watch/fgJ3
查看全文

Corbus(CRBP) 05月11日 11时08分

查看全文
  • 首页 上一页 1 2 3 下一页 尾页  每页20条/共229